Shareholder Votes

Fluent, Inc. shareholders approved The approval of an adjournment of the Annual Meeting, if necessary or advisable, to solicit additional proxies in favor of any of the foregoing proposals if there are not sufficient votes to approve any such proposals at the 2026-06-17 meeting.

“(8) The approval of an adjournment of the Annual Meeting, if necessary or advisable, to solicit additional proxies in favor of any of the foregoing proposals if there are not sufficient votes to approve any such proposals: For Against Abstain 24,084,952 758,043 90,096”

Fluent, Inc. shareholders approved The approval of an amendment to the Fluent, Inc. 2022 Omnibus Equity Incentive Plan to increase the number of shares of common stock reserved thereunder to 5,566,666 shares from 3,666,666 shares at the 2026-06-17 meeting.

“(7) The approval of an amendment to the Fluent, Inc. 2022 Omnibus Equity Incentive Plan to increase the number of shares of common stock reserved thereunder to 5,566,666 shares from 3,666,666 shares: For Against Abstain Broker Non-Vote 19,728,486 1,365,509 8,983 3,830,113”

Fluent, Inc. shareholders approved The approval of an Amended and Restated Certificate of Incorporation to provide for exculpation of officers as permitted by recent amendments to Delaware law at the 2026-06-17 meeting.

“(6) The approval of an Amended and Restated Certificate of Incorporation to provide for exculpation of officers as permitted by recent amendments to Delaware law: For Against Abstain Broker Non-Vote 20,923,709 173,436 5,833 3,830,113”

Fluent, Inc. shareholders approved The approval, for purposes of complying with Nasdaq Listing Rules 5635(b) and 5635(c), pre-funded warrants issued pursuant to those certain securities purchase agreements dated as of August 19, 2025 to certain of the Company’s directors and/or officers and any shares of the Company’s common stock is at the 2026-06-17 meeting.

“(5) The approval, for purposes of complying with Nasdaq Listing Rules 5635(b) and 5635(c), pre-funded warrants issued pursuant to those certain securities purchase agreements dated as of August 19, 2025 to certain of the Company’s directors and/or officers and any shares of the Company’s common stock issuable upon exercise thereof: For Against Abstain Broker Non-Vote 20,976,658 120,326 5,994 3,830,113”

Fluent, Inc. shareholders approved The approval, or purposes of complying with Nasdaq Listing Rules 5635(b) and 5635(c), pre-funded warrants issued pursuant to those certain securities purchase agreements dated as of May 15, 2025 to certain of the Company’s directors and/or officers and any shares of the Company’s common stock issuab at the 2026-06-17 meeting.

“(4) The approval, or purposes of complying with Nasdaq Listing Rules 5635(b) and 5635(c), pre-funded warrants issued pursuant to those certain securities purchase agreements dated as of May 15, 2025 to certain of the Company’s directors and/or officers and any shares of the Company’s common stock issuable upon exercise thereof: For Against Abstain Broker Non-Vote 20,976,577 120,411 5,990 3,830,113”

Fluent, Inc. shareholders approved The ratification of the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 at the 2026-06-17 meeting.

“(3) The ratification of the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026: For Against Abstain 24,642,074 257,660 33,357”

Fluent, Inc. shareholders approved The approval, on an advisory basis, of the 2025 Compensation of the Company's named executive officers (Say-on-Pay) at the 2026-06-17 meeting.

“(2) The approval, on an advisory basis, of the 2025 Compensation of the Company's named executive officers (Say-on-Pay): For Against Abstain Broker Non-Vote 20,724,713 369,203 9,062 3,830,113”

Fluent, Inc. shareholders approved Election of seven directors to serve for a one year term until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified at the 2026-06-17 meeting.

“On June 17, 2026, Fluent, Inc. (the " Company ") held its 2026 Annual Meeting of Stockholders (the " Annual Meeting ") virtually.”

Angel Studios, Inc. shareholders approved Adoption of Amended Charter at the 2026-06-17 meeting.

“On June 17, 2026, there were 56,735,246 shares of Class B Common Stock outstanding. Stockholders holding an aggregate of 43,944,071 shares of Class B Common Stock, representing 77.45% of the outstanding Class B Common Stock, consented to the adoption of the Amended Charter.”

LendingTree, Inc. shareholders approved Ratification of Independent Registered Public Accounting Firm at the 2026-06-17 meeting.

“Proposal 3. Ratification of Independent Registered Public Accounting Firm At the Annual Meeting, stockholders approved the ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the 2026 fiscal year. The result of the votes to approve the ratification of the appointment of PricewaterhouseCoopers LLP was as follows: For Against Abstain 11,516,689 87,911 5,556”

LendingTree, Inc. shareholders approved Advisory (Non-Binding) Vote to Approve Executive Compensation at the 2026-06-17 meeting.

“Proposal 2. Advisory (Non-Binding) Vote to Approve Executive Compensation At the Annual Meeting, stockholders approved, on an advisory basis, the Company’s executive compensation. The result of the votes to approve the executive compensation was as follows: For Against Abstain Broker Non-Votes 8,221,470 149,183 3,317 3,236,186”

LendingTree, Inc. shareholders approved Election of nine directors named in the proxy statement at the 2026-06-17 meeting.

“Proposal 1. Election of Directors At the Annual Meeting, the following nine nominees for election to the Company’s board of directors were elected, each for a one-year term or until their successor has been duly elected and qualified , or until such director’s earlier resignation, removal or death : For Against Abstain Broker Non-Votes Gabriel Dalporto 8,215,779 153,010 5,181 3,236,186 Thomas M. Davidson, Jr. 7,421,686 946,075 6,209 3,236,186 Mark Ernst 8,214,074 154,254 5,642 3,236,186 Robin Henderson 8,173,915 193,464 6,591 3,236,186 Steven Ozonian 8,134,299 234,084 5,587 3,236,186 Scott Peyree 8,223,802 141,630 8,538 3,236,186 Diego Rodriguez 8,220,484 146,877 6,609 3,236,186 Saras Sarasvathy 8,197,435 168,840 7,695 3,236,186 G. Kennedy Thompson 8,199,626 167,729 6,615 3,236,186”

DXP ENTERPRISES INC shareholders approved Advisory vote on compensation of named executive officers. at the 2026-06-12 meeting.

“PROPOSAL 2: ADVISORY VOTE ON COMPENSATION OF NAMED EXECUTIVE OFFICERS With respect to the number of shares of Common Stock that were voted for, voted against, and were withheld from voting for proposal #2 to approve, as a non-binding advisory vote, executive compensation are set forth below: For 13,230,682 % For 97.6% Against 313,927 Abstain 17,023 Broker Non-Votes* 728,837 Vote Results Approved”

DXP ENTERPRISES INC shareholders approved Election of six (6) nominees for director. at the 2026-06-12 meeting.

“The shareholders: (1) Voted to elect each of the six (6) nominees for director.”

Acrivon Therapeutics, Inc. shareholders approved Approval of the Amendment and Restatement of the Company's 2022 Equity Incentive Plan.

“Votes were cast as follows: For Against Abstain Broker Non-Votes 20,546,400 3,757,400 104,757 6,928,436”

Acrivon Therapeutics, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm.

“Proposal Two: Ratification of Appointment of Independent Registered Public Accounting Firm.”

Acrivon Therapeutics, Inc. shareholders approved Election of Michael Tomsicek, M.B.A. and Charles Baum, M.D., Ph.D. as Class I Directors.

“Votes were cast as follows: For Withheld Broker Non-Votes Michael Tomsicek, M.B.A. 24,020,408 1,229,385 6,087,200 Charles Baum, M.D., Ph.D. 23,657,074 1,592,719 6,087,200”

BlockchAIn Digital Infrastructure, Inc. shareholders approved Ratification of Auditors at the 2026-06-16 meeting.

“Stockholders ratified the appointment of Carr, Riggs & Ingram, L.L.C. to serve as the Company’s independent registered public accounting firm for the fiscal years ending December 31, 2025 and 2026. The voting results were as follows: For Against Abstain Broker Non- Votes 27,782,849 4,063 1,602 N/A”

BlockchAIn Digital Infrastructure, Inc. shareholders approved Election of Directors at the 2026-06-16 meeting.

“Stockholders elected the Company’s two nominees for Class I directors each to serve for a term of three years or until their respective successor is duly elected and qualified. For Against Abstain Broker Non-Votes Daniel Nelson 26,608,142. 0 11,115 0 Hongfei Zhang 26,585,005 0 34,215 0”

Citizens Community Bancorp Inc. shareholders approved Ratification of the Appointment of the Company's Independent Registered Public Accounting Firm: Crowe LLP at the 2026-06-16 meeting.

“4. Proposal 4 : Ratification of the Appointment of the Company's Independent Registered Public Accounting Firm: The Stockholders approved the proposal to ratify the appointment by the Company's Audit Committee of Crowe LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. The results of the vote were as follows: Votes For Votes Against Abstentions Broker Non-Votes 7,230,943 602,361 4,363 —”

Citizens Community Bancorp Inc. shareholders approved Advisory (non-binding) vote on the executive compensation of the Company's named executive officers at the 2026-06-16 meeting.

“3. Proposal 3 : Advisory (non-binding) vote on the executive compensation of the Company's named executive officers: The Stockholders approved the advisory (non-binding) proposal regarding the compensation of the Company's named executive officers as disclosed in the Proxy Statement for the Annual Meeting. The results of the vote were as follows: Votes For Votes Against Abstentions Broker Non-Votes 5,548,511 1,154,581 29,613 1,104,962”

Citizens Community Bancorp Inc. shareholders approved 2026 Omnibus Incentive Plan at the 2026-06-16 meeting.

“2. Proposal 2 : 2026 Omnibus Incentive Plan: The Stockholders approved the 2026 Omnibus Incentive Plan. The results of the vote were as follows: Votes For Votes Against Abstentions Broker Non-Votes 5,872,050 853,213 7,442 1,104,962”

Citizens Community Bancorp Inc. shareholders approved Election of Directors: Michael Conner, Francis Felber and Nicholas Amundsen at the 2026-06-16 meeting.

“1. Proposal 1 : Election of Directors: Michael Conner, Francis Felber and Nicholas Amundsen were elected directors of the Company. The results of the vote were as follows: Name Votes For Votes Withheld Broker Non-Votes Michael Conner 5,621,999 1,110,706 1,104,962 Francis Felber 5,429,851 1,302,854 1,104,962 Nicholas Amundsen 5,587,434 1,145,271 1,104,962”

ARDELYX, INC. shareholders approved Approval of the Equity Plan Amendment at the 2026-06-16 meeting.

“Proposal No. 5 - Approval of the Equity Plan Amendment The Company’s stockholders approved the Equity Plan Amendment. Votes For Votes Against Abstentions Broker Non-Votes 77,395,305 69,720,789 674,708 41,417,148”

ARDELYX, INC. shareholders approved Ratification of Appointment of Independent Registered Accounting Firm at the 2026-06-16 meeting.

“Proposal No. 4 - Ratification of Appointment of Independent Registered Accounting Firm The Company’s stockholders ratified the appointment, by the Audit Committee of the Board, of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026. Votes For Votes Against Abstentions Broker Non-Votes 186,182,340 2,012,970 1,012,640 —”

ARDELYX, INC. shareholders approved Approval, on a non-binding, advisory basis, of the Say-On-Frequency proposal at the 2026-06-16 meeting.

“Proposal No. 3 - Approval, on a non-binding, advisory basis, of the Say-On-Frequency proposal The Company’s stockholders approved, on a non-binding, advisory basis, the frequency of a Say-On-Pay vote occurring every one (1) year. One Year Two Years Three Years Abstentions Broker Non-Votes 141,539,889 671,451 3,426,669 2,152,793 41,417,148”

ARDELYX, INC. shareholders approved Approval, on a non-binding, advisory basis, of the Say-On-Pay proposal at the 2026-06-16 meeting.

“Proposal No. 2 - Approval, on a non-binding, advisory basis, of the Say-On-Pay proposal The Company’s stockholders approved, on a non-binding, advisory basis, the Say-On-Pay proposal. Votes For Votes Against Abstentions Broker Non-Votes 137,617,786 9,413,395 759,621 41,417,148”

ARDELYX, INC. shareholders approved Election of Directors at the 2026-06-16 meeting.

“Proposal No. 1 - Election of Directors The Company’s stockholders elected the Class III director nominees below to the Company’s Board to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected. Class II Director Nominees Votes For Votes Withheld Broker Non-Votes Robert Bazemore 143,174,322 4,616,480 41,417,148 Muna Bhanji, R.Ph 121,228,081 26,562,721 41,417,148 Richard Rodgers 141,495,737 6,295,065 41,417,148”

Fly-E Group, Inc. shareholders approved Approval of amendment to Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Common Stock by a ratio in a range of 1-for-5 to 1-for-100, with such ratio to be determined in the discretion of the Board of Directors and with such action to be effected at such time at the 2026-06-17 meeting.

“At the Meeting, the shareholders approved the proposal to amend the Company’s Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company’s Common Stock by a ratio in a range of 1-for-5 to 1-for-100, with such ratio to be determined in the discretion of the Board of Directors of the Company and with such action to be effected at such time and date, if at all, as determined by the Board of Directors of the Company within one year after the conclusion of the Meeting. The voting results were as follows: FOR AGAINST ABSTAIN 917,455.31 14,891.70 274.50”

Fly-E Group, Inc. shareholders approved Ratification of selection of Fortune CPA, Inc. as independent registered public accounting firm to audit the consolidated financial statements for the fiscal year ended March 31, 2026 at the 2026-06-17 meeting.

“At the Meeting, the shareholders approved the proposal to ratify the selection of Fortune CPA, Inc. as the Company’s independent registered public accounting firm to audit the Company’s consolidated financial statements for the fiscal year ended March 31, 2026. The voting results were as follows: FOR AGAINST ABSTAIN 930,191.66 577.70 1,852.15”

Fly-E Group, Inc. shareholders approved Election of Directors at the 2026-06-17 meeting.

“At the Meeting, all of the following four nominees were elected to the Company’s Board of Directors, in accordance with the voting results listed below, to serve until the 2026 Annual Meeting and until their successors are duly elected and qualified, or until their respective earlier death, resignation or removal. The voting results were as follows: Nominee For Against Broker Non-Vote Lisa Fan 926,763.58 3,944.74 698,089.00 Leqi Dong 926,456.48 4,251.74 698,089.00 Dongperez Hua 926,462.18 4,246.14 698,089.00 Chun Min (Max) Lin 926,461.58 4,246.74 698,089.00”

Melar Acquisition Corp. I/Cayman shareholders approved Auditor Ratification Proposal to ratify the selection by the Board’s Audit Committee of WithumSmith+Brown, PC to serve as the Company’s independent registered public accounting firm for the year ending December 31, 2026.

“The Auditor Ratification Proposal was approved with the following vote from the holders of the Ordinary Shares: For Against Abstentions Broker Non-Votes 16,788,360 3,458,663 0 0”

Melar Acquisition Corp. I/Cayman shareholders approved Extension Amendment to extend the date by which the Company must consummate a Business Combination on a monthly basis, up to six (6) times, from June 20, 2026 through December 20, 2026, or such earlier date as determined by the Board.

“The Extension Amendment Proposal was approved with the following vote from the holders of the Ordinary Shares: For Against Abstentions Broker Non-Votes 15,687,094 3,284,050 0 1,275,879”

MAXCYTE, INC. shareholders approved Ratification of the Audit Committee’s selection of CohnReznick LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026 at the 2026-06-17 meeting.

“Proposal 2 – Ratification of the Audit Committee’s selection of CohnReznick LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026: Votes For Votes Against Abstentions 70,227,193 46,732 30,256”

MAXCYTE, INC. shareholders approved Election of Class II Directors at the 2026-06-17 meeting.

“Proposal 1 – Election of Class II Directors: ​ ​ ​ ​ Nominee For ​ Withhold ​ Broker Non-Votes Patrick Balthrop 39,760,379 ​ 12,728,826 ​ 17,814,976 Cynthia Collins 46,886,614 ​ 5,602,591 ​ 17,814,976 Stanley Erck 40,908,701 ​ 11,580,504 ​ 17,814,976”

Dogwood Therapeutics, Inc. shareholders approved Advisory vote on the compensation of our named executive officers at the 2026-06-16 meeting.

“5. Advisory vote on the compensation of our named executive officers (“Say-on-Pay” proposal). The Company’s stockholders approved, by an advisory vote, the compensation of its named executive officers, with the following votes tabulated: For Against Abstain Broker Non-Vote 28,662,176 25,962 3,441 3,099,921”

Dogwood Therapeutics, Inc. shareholders approved Advisory vote on the frequency of future advisory votes on named executive officer compensation at the 2026-06-16 meeting.

“4. Advisory vote on the frequency of future advisory votes on named executive officer compensation (“Say-on-Frequency” proposal). The Company’s stockholders approved, by an advisory vote, the Say-on-Frequency proposal, with the following votes tabulated: ​ One Year ​ Two Years Three Years Abstain ​ Broker Non-Vote ​ 28,682,394 2,534 3,655 ​ 2,996 3,099,921”

Dogwood Therapeutics, Inc. shareholders approved Approval of the amendment to the Dogwood Therapeutics, Inc. Certificate of Incorporation to increase the number of shares of common stock and preferred stock authorized for issuance at the 2026-06-16 meeting.

“3. Approval of the amendment to the Dogwood Therapeutics, Inc. Certificate of Incorporation to increase the number of shares of common stock and preferred stock authorized for issuance. The amendment to the Certificate of Incorporation was approved with the following votes tabulated: For Against Abstain Broker Non-Vote 28,431,012 243,744 16,823 3,099,921”

Dogwood Therapeutics, Inc. shareholders approved Ratification of the appointment of Forvis Mazars, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-16 meeting.

“2. Ratification of the appointment of Forvis Mazars, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. The appointment of Forvis Mazars, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified, with the following votes tabulated: ​ For Against Abstain Broker Non-Vote 31,778,192 2,397 10,911 -”

Dogwood Therapeutics, Inc. shareholders approved Election of Directors at the 2026-06-16 meeting.

“1. Election of Directors. The following seven nominees were elected to serve as directors of the Company, with the following votes tabulated: ​ ​ ​ For Withheld Broker Non-Vote Abel De La Rosa, Ph.D. 28,684,078 7,501 3,099,921 Greg Duncan 28,682,224 9,355 3,099,921 David Keefer 28,680,250 11,329 3,099,921 John C. Thomas, Jr. 28,683,680 7,899 3,099,921 Melvin Toh, M.B.B.S. 28,682,093 9,486 3,099,921 Richard J. Whitley, M.D. 28,678,320 13,259 3,099,921 Alan Yu 28,678,659 12,920 3,099,921”

Annovis Bio, Inc. shareholders approved Advisory (Non-Binding) Vote on the Compensation of the Company's Named Executive Officers at the 2026-06-17 meeting.

“The compensation of the Company's named executive officers was approved b y the stockholders o n an advisory (non-binding basis), by the following vote: Broker Non-Vote For Against Abstain Broker Non-Vote 8,067,931 901,342 185,701 12,550,139”

Annovis Bio, Inc. shareholders approved Amendment to the Annovis Bio, Inc. 2019 Equity Incentive Plan to increase the number of shares that may be issued under the Plan from 4,000,000 to 5,500,000 and to increase the maximum number of shares that may be awarded in any one year from 400,000 to 600,000 shares at the 2026-06-17 meeting.

“The amendment to the Annovis Bio, Inc. 2019 Equity Incentive Plan to i ncrease the number of shares that may be issued under the Plan from 4,000,000 to 5,500,000 and to increase the maximum number of shares that may be awarded in any one year from 400,000 to 600,000 shares, was approved by stockholders by the following vote: For Against Abstain Broker Non-Vote 8,089,891 899,671 165,409 12,550,142”

Annovis Bio, Inc. shareholders approved Ratification of the Company's Independent Auditors at the 2026-06-17 meeting.

“The ratification of the appointment of Ernst & Young LLP was approved by stockholders by the following vote: For Against Abstain 20,634,176 568,155 502,782”

Annovis Bio, Inc. shareholders approved Election of Directors at the 2026-06-17 meeting.

“Election of Directors All of the following five nominees were elected to the Company's Board of Directors, in accordance with the voting results listed below, to serve for a term of one year, until the next Annual Meeting and until their successors have been duly elected and have qualified.”

BEST BUY CO INC shareholders rejected Report on Risks of Non-Fiduciary Executive Compensation Metrics at the 2026-06-12 meeting.

“4. Vote on a Shareholder Proposal. The shareholder proposal entitled “Report on Risks of Non-Fiduciary Executive Compensation Metrics,” was rejected by shareholders based upon the following votes: For Against Abstain Broker Non-Vote 2,717,793 172,239,179 1,069,453 16,021,509”

BEST BUY CO INC shareholders approved Advisory Vote on Executive Compensation at the 2026-06-12 meeting.

“3. Advisory Vote on Executive Compensation. The proposal relating to the non-binding advisory vote to approve the executive compensation of the registrant was approved by shareholders based upon the following votes: For Against Abstain Broker Non-Vote 156,029,981 19,570,647 425,797 16,021,509”

BEST BUY CO INC shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-12 meeting.

“2. Ratification of Appointment of Independent Registered Public Accounting Firm . The appointment of Deloitte & Touche LLP as the registrant’s independent registered public accounting firm for the fiscal year ending January 30, 2027, was ratified based upon the following votes: For Against Abstain Broker Non-Vote 178,210,655 13,484,723 352,556 —”

BEST BUY CO INC shareholders approved Election of Directors at the 2026-06-12 meeting.

“1. Election of Directors. The following individuals were elected as directors for a term of one year, based upon the following votes: Director Nominee For Against Abstain Broker Non-Vote Corie S. Barry 174,219,448 1,435,568 371,409 16,021,509 Lisa M. Caputo 169,214,311 6,445,797 366,317 16,021,509 Meghan C. Frank 151,714,690 23,937,869 373,866 16,021,509 A. Dylan Jadeja 174,568,714 1,075,796 381,915 16,021,509 David W. Kenny 171,567,526 4,087,708 371,191 16,021,509 David C. Kimbell 171,080,295 4,569,542 376,588 16,021,509 Mario J. Marte 171,924,438 3,721,006 380,981 16,021,509 Karen A. McLoughlin 172,747,823 2,910,656 367,946 16,021,509 Claudia F. Munce 172,419,287 3,239,814 367,324 16,021,509 Richelle P. Parham 174,044,370 1,605,771 376,284 16,021,509 Steven E. Rendle 151,075,008 24,572,718 378,699 16,021,509 Sima D. Sistani 152,266,243 23,379,510 380,672 16,021,509 Melinda D. Whittington 151,096,604 24,552,830 376,991 16,021,509”

BayCom Corp shareholders approved Ratification of the appointment of Baker Tilly US, LLP as independent registered public accounting firm for the year ending December 31, 2026 at the 2026-06-16 meeting.

“The Company’s shareholders approved the ratification of the appointment of Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026.”

BayCom Corp shareholders approved Advisory (non-binding) vote on executive compensation at the 2026-06-16 meeting.

“The Company’s shareholders approved the advisory (non-binding) vote on executive compensation.”